Ratiopharm
Ratiopharm is a German pharmaceutical company that is Europe's leading generics brand.
 | |
| Type | Private |
|---|---|
| Industry | Pharmaceutical industry |
| Founded | 1974 |
| Founders | Merckle family |
| Headquarters | Ulm, Germany |
Key people | Adolf Merckle, founder Oliver Windholz, CEO |
| Products | Pharmaceuticals and generic medication. |
| Revenue |  € 1.8 billion (2007) |
Number of employees | 5,417 (2007) |
| Parent | Teva Pharmaceutical Industries |
| Website | Ratiopharm.com |
Ratiopharm was owned by Adolf Merckle and makes generic pharmaceuticals. They are based in Ulm, Germany, and products being distributed in over 35 countries worldwide.
On March 18, 2010, Teva announced that it planned to acquire Ratiopharm for US$5 billion.[1][2] On August 10, 2010, Teva announced that it had completed its acquisition of Ratiopharm.[3]
See also
References
- NATASHA SINGER (March 18, 2010). "Teva to Acquire Top German Generics Maker for $5 Billion". The New York Times. Retrieved March 18, 2010.
- Teva to Acquire Generics Firm The Wall Street Journal March 19, 2010
- "Teva Completes Acquisition of Ratiopharm". August 10, 2010. Archived from the original on August 18, 2010. Retrieved August 20, 2010.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.